vs

Side-by-side financial comparison of DOMO, INC. (DOMO) and MEDIFAST INC (MED). Click either name above to swap in a different company.

DOMO, INC. is the larger business by last-quarter revenue ($79.4M vs $75.1M, roughly 1.1× MEDIFAST INC). On growth, DOMO, INC. posted the faster year-over-year revenue change (-0.5% vs -36.9%). DOMO, INC. produced more free cash flow last quarter ($1.1M vs $-6.6M). Over the past eight quarters, DOMO, INC.'s revenue compounded faster (-0.5% CAGR vs -34.4%).

Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

DOMO vs MED — Head-to-Head

Bigger by revenue
DOMO
DOMO
1.1× larger
DOMO
$79.4M
$75.1M
MED
Growing faster (revenue YoY)
DOMO
DOMO
+36.4% gap
DOMO
-0.5%
-36.9%
MED
More free cash flow
DOMO
DOMO
$7.7M more FCF
DOMO
$1.1M
$-6.6M
MED
Faster 2-yr revenue CAGR
DOMO
DOMO
Annualised
DOMO
-0.5%
-34.4%
MED

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DOMO
DOMO
MED
MED
Revenue
$79.4M
$75.1M
Net Profit
$-10.4M
Gross Margin
74.2%
69.4%
Operating Margin
-8.7%
-10.4%
Net Margin
-13.1%
Revenue YoY
-0.5%
-36.9%
Net Profit YoY
44.6%
EPS (diluted)
$-0.25
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOMO
DOMO
MED
MED
Q4 25
$79.4M
$75.1M
Q3 25
$79.7M
$89.4M
Q2 25
$80.1M
$105.6M
Q1 25
$78.8M
$115.7M
Q4 24
$79.8M
$119.0M
Q3 24
$78.4M
$140.2M
Q2 24
$80.1M
$168.6M
Q1 24
$80.2M
$174.7M
Net Profit
DOMO
DOMO
MED
MED
Q4 25
$-10.4M
Q3 25
$-22.9M
$-2.3M
Q2 25
$-18.1M
$2.5M
Q1 25
$-17.7M
$-772.0K
Q4 24
$-18.8M
Q3 24
$-19.5M
$1.1M
Q2 24
$-26.0M
$-8.2M
Q1 24
$-18.7M
$8.3M
Gross Margin
DOMO
DOMO
MED
MED
Q4 25
74.2%
69.4%
Q3 25
74.8%
69.5%
Q2 25
74.2%
72.6%
Q1 25
74.4%
72.8%
Q4 24
75.0%
74.1%
Q3 24
74.3%
75.4%
Q2 24
74.1%
73.2%
Q1 24
76.3%
72.8%
Operating Margin
DOMO
DOMO
MED
MED
Q4 25
-8.7%
-10.4%
Q3 25
-9.1%
-4.6%
Q2 25
-17.9%
-1.0%
Q1 25
-15.6%
-1.1%
Q4 24
-13.9%
0.6%
Q3 24
-18.5%
1.5%
Q2 24
-26.8%
-4.7%
Q1 24
-16.6%
4.5%
Net Margin
DOMO
DOMO
MED
MED
Q4 25
-13.1%
Q3 25
-28.8%
-2.5%
Q2 25
-22.5%
2.3%
Q1 25
-22.4%
-0.7%
Q4 24
-23.5%
Q3 24
-24.9%
0.8%
Q2 24
-32.5%
-4.8%
Q1 24
-23.3%
4.8%
EPS (diluted)
DOMO
DOMO
MED
MED
Q4 25
$-0.25
$-1.64
Q3 25
$-0.56
$-0.21
Q2 25
$-0.45
$0.22
Q1 25
$-0.45
$-0.07
Q4 24
$-0.48
$0.08
Q3 24
$-0.51
$0.10
Q2 24
$-0.69
$-0.75
Q1 24
$-0.51
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOMO
DOMO
MED
MED
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
$124.2M
Stockholders' EquityBook value
$-191.9M
$198.9M
Total Assets
$201.6M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOMO
DOMO
MED
MED
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$47.2M
$162.7M
Q1 25
$45.3M
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$61.2M
$163.5M
Q1 24
$60.9M
$156.4M
Total Debt
DOMO
DOMO
MED
MED
Q4 25
$124.2M
Q3 25
$121.9M
Q2 25
$119.7M
Q1 25
$117.7M
Q4 24
$115.6M
Q3 24
$115.2M
Q2 24
$114.1M
Q1 24
$113.5M
Stockholders' Equity
DOMO
DOMO
MED
MED
Q4 25
$-191.9M
$198.9M
Q3 25
$-191.5M
$214.7M
Q2 25
$-178.7M
$216.0M
Q1 25
$-177.2M
$211.0M
Q4 24
$-171.2M
$210.1M
Q3 24
$-166.4M
$207.3M
Q2 24
$-163.5M
$205.3M
Q1 24
$-153.5M
$211.0M
Total Assets
DOMO
DOMO
MED
MED
Q4 25
$201.6M
$248.0M
Q3 25
$195.7M
$268.2M
Q2 25
$189.7M
$269.3M
Q1 25
$214.3M
$280.0M
Q4 24
$190.2M
$284.2M
Q3 24
$197.8M
$291.2M
Q2 24
$204.4M
$293.5M
Q1 24
$225.7M
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOMO
DOMO
MED
MED
Operating Cash FlowLast quarter
$3.4M
$-5.3M
Free Cash FlowOCF − Capex
$1.1M
$-6.6M
FCF MarginFCF / Revenue
1.4%
-8.8%
Capex IntensityCapex / Revenue
2.9%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.9M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOMO
DOMO
MED
MED
Q4 25
$3.4M
$-5.3M
Q3 25
$3.4M
$12.1M
Q2 25
$4.0M
$-3.4M
Q1 25
$8.9M
$3.4M
Q4 24
$-13.7M
$-4.9M
Q3 24
$-6.2M
$9.1M
Q2 24
$1.9M
$13.1M
Q1 24
$5.4M
$7.3M
Free Cash Flow
DOMO
DOMO
MED
MED
Q4 25
$1.1M
$-6.6M
Q3 25
$1.0M
$10.8M
Q2 25
$1.0M
$-4.8M
Q1 25
$6.7M
$1.9M
Q4 24
$-16.2M
$-7.2M
Q3 24
$-8.4M
$7.7M
Q2 24
$-625.0K
$11.1M
Q1 24
$2.9M
$5.4M
FCF Margin
DOMO
DOMO
MED
MED
Q4 25
1.4%
-8.8%
Q3 25
1.3%
12.0%
Q2 25
1.3%
-4.5%
Q1 25
8.5%
1.6%
Q4 24
-20.3%
-6.1%
Q3 24
-10.7%
5.5%
Q2 24
-0.8%
6.6%
Q1 24
3.6%
3.1%
Capex Intensity
DOMO
DOMO
MED
MED
Q4 25
2.9%
1.8%
Q3 25
2.9%
1.5%
Q2 25
3.7%
1.3%
Q1 25
2.8%
1.3%
Q4 24
3.2%
1.9%
Q3 24
2.8%
1.0%
Q2 24
3.2%
1.1%
Q1 24
3.1%
1.1%
Cash Conversion
DOMO
DOMO
MED
MED
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOMO
DOMO

Subscription$71.9M91%
Professional Servicesand Other$7.5M9%

MED
MED

Segment breakdown not available.

Related Comparisons